Brown Brothers Harriman & Co. - Net Worth and Insider Trading

Brown Brothers Harriman & Co. Net Worth

The estimated net worth of Brown Brothers Harriman & Co. is at least $508 Million dollars as of 2025-06-05. Brown Brothers Harriman & Co. is the 2502 Approved lending agent of Medlive Technology Co Ltd and owns about 35,891,356 shares of Medlive Technology Co Ltd (HKSE:02192) stock worth over $508 Million. Details can be seen in Brown Brothers Harriman & Co.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brown Brothers Harriman & Co. has not made any transactions after 2022-10-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brown Brothers Harriman & Co. owns 1 companies in total, including Medlive Technology Co Ltd (HKSE:02192) .

Click here to see the complete history of Brown Brothers Harriman & Co.’s form 4 insider trades.

Insider Ownership Summary of Brown Brothers Harriman & Co.

Ticker	Company	Transaction Date	Type of Owner
HKSE:02192	Medlive Technology Co Ltd	2022-10-10	2502 Approved lending agent

Brown Brothers Harriman & Co. Latest Holdings Summary

Brown Brothers Harriman & Co. currently owns a total of 1 stock. Brown Brothers Harriman & Co. owns 35,891,356 shares of Medlive Technology Co Ltd (HKSE:02192) as of October 10, 2022, with a value of $508 Million.

Latest Holdings of Brown Brothers Harriman & Co.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02192	Medlive Technology Co Ltd	2022-10-10	35,891,356	14.16	508,221,601

Holding Weightings of Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co. Form 4 Trading Tracker

According to the SEC Form 4 filings, Brown Brothers Harriman & Co. has made a total of 3 transactions in Medlive Technology Co Ltd (HKSE:02192) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Medlive Technology Co Ltd is the sale of 872,000 shares on October 10, 2022, which brought Brown Brothers Harriman & Co. around $0.

Insider Trading History of Brown Brothers Harriman & Co.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brown Brothers Harriman & Co. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brown Brothers Harriman & Co. Ownership Network

Ownership Network List of Brown Brothers Harriman & Co.

No Data

Ownership Network Relation of Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co. Owned Company Details

What does Medlive Technology Co Ltd do?

Who are the key executives at Medlive Technology Co Ltd?

Brown Brothers Harriman & Co. is the 2502 Approved lending agent of Medlive Technology Co Ltd. Other key executives at Medlive Technology Co Ltd include 2201 Interest of corporation controlled by you Fil Limited , 2201 Interest of corporation controlled by you Pandanus Associates Inc. , and 2201 Interest of corporation controlled by you Pandanus Partners L.p. .

Medlive Technology Co Ltd (HKSE:02192) Insider Trades Summary

Over the past 18 months, Brown Brothers Harriman & Co. made no insider transaction in Medlive Technology Co Ltd (HKSE:02192). Other recent insider transactions involving Medlive Technology Co Ltd (HKSE:02192) include a net sale of 6,341,000 shares made by Fil Limited , a net sale of 6,341,000 shares made by Pandanus Partners L.p. , and a net sale of 6,341,000 shares made by Pandanus Associates Inc. .

In summary, during the past 3 months, insiders sold 3,592,500 shares of Medlive Technology Co Ltd (HKSE:02192) in total and bought 0 shares, with a net sale of 3,592,500 shares. During the past 18 months, 20,007,000 shares of Medlive Technology Co Ltd (HKSE:02192) were sold and 984,000 shares were bought by its insiders, resulting in a net sale of 19,023,000 shares.

Medlive Technology Co Ltd (HKSE:02192)'s detailed insider trading history can be found in Insider Trading Tracker table.

Medlive Technology Co Ltd Insider Transactions

No Available Data

Brown Brothers Harriman & Co. Mailing Address

Above is the net worth, insider trading, and ownership report for Brown Brothers Harriman & Co.. Currently GuruFocus does not have mailing address information for Brown Brothers Harriman & Co..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.